Read More Pharma Industry News How Levicept Ltd. is advancing neurotrophin-3 inhibition in osteoarthritis treatment Levicept Ltd.’s LEVI-04 Phase II data could reshape osteoarthritis treatment. Discover what this means for investors, regulators, and drug pipelines. bySoujanya RaviApril 27, 2026